N

NVS

Novartis AG
HealthcareDrug Manufacturers - General|New York Stock Exchange|CH

Price

$154.03

Market Cap

$297.32B

Beta

0.52

P/E

21.1

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+8.56%
EPS Growth (YoY)+21.60%
Revenue CAGR 3Y+4.10%
P/E Ratio21.1
PEG Ratio1.00
FCF Yield+5.26%
Debt / Equity0.80
Interest Coverage15.3x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for NVS.

NVS — Novartis AG Stock Analysis | Tessera Alpha